About
Robert Hariri, MD, PhD is the regenerative-science founder in the Fountain Life group. He trained through Cornell's Tri-Institutional MD-PhD program and built his career translating cell biology into companies, especially around human-placenta-derived stem cells. His work moved through Anthrogenesis (acquired by Celgene) and Celularity Inc. (Nasdaq: CELU), where he serves as Chairperson, Founder, and CEO. He also co-founded Human Longevity Inc. with Craig Venter and Peter Diamandis, MD, giving Fountain Life a founder with direct regenerative-medicine and healthspan-company experience.
What to Know
Signature approach
Hariri's pattern is bench-to-company translation: move a biological discovery through patents, manufacturing, regulatory pathways, and commercial infrastructure. For Fountain Life, that matters most on the regenerative-science side of the model. He brings a cellular-therapeutics worldview to a company that pairs diagnostics with optional restorative therapeutics.
What sets them apart
- Placental stem cell pioneer. His patent estate has been recognized as one of the field's important bodies of work, with 170+ issued and pending patents.
- Public-company operator. Founder, Chairperson, and CEO of Celularity Inc., after earlier leadership in Celgene's cellular therapeutics work.
- Healthspan-company track record. Co-founded Human Longevity Inc. before Fountain Life, linking genomics, diagnostics, and regenerative science across multiple ventures.
Expertise
Focus areas
Affiliations
Co-Founder
Thought Leadership
Notable Collaborators
- Peter Diamandis · Co-founder of Fountain Life and Human Longevity Inc.
- Tony Robbins · Co-founder of Fountain Life
- Craig Venter · Co-founder of Human Longevity Inc.
Other specialists at Fountain Life
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.